A randomized clinical trial of mindfulness-based cognitive therapy for women with irritable bowel syndrome-Effects and mechanisms.
Study Goal
The researchers aimed to evaluate the effects of mindfulness-based cognitive therapy adapted for IBS (MBCT-IBS) on symptom reduction and quality of life, as well as investigate its therapeutic mechanisms.
Results Summary
The MBCT-IBS group reported significantly greater reductions in IBS symptoms and improvements in quality of life compared to the control group, with potential mechanisms involving reduced maladaptive illness cognitions and changes in self-processing.
Population
67 female patients with irritable bowel syndrome (IBS).
Effective Dosage
Not specified
Duration
6 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS) | decrease | IBS symptoms | female patients with IBS | - | significantly greater reductions | #1 |
mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS) | decrease | maladaptive illness cognitions | female patients with IBS | - | significantly greater reductions | #2 |
mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS) | decrease | self-referent processing of illness and health | female patients with IBS | - | significantly greater reductions | #3 |
mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS) | increase | nonjudgmental awareness | female patients with IBS | - | significantly greater increases | #4 |
mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS) | increase | quality of life | female patients with IBS | - | increase | #5 |
OBJECTIVE: Irritable bowel syndrome (IBS) is a chronic disorder of brain-gut interaction. Previous studies suggest that mindfulness could be therapeutic for IBS patients, however no study has evaluated the effects of mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS). A 6-week MBCT-IBS course was designed to reduce symptoms and increase quality of life. This study aimed to evaluate the effects of MBCT-IBS and to investigate its therapeutic mechanisms in a randomized controlled trial. METHOD: Sixty-seven female patients with IBS were randomized to MBCT-IBS (MG; RESULTS: The MG reported significantly greater reductions in IBS symptoms ( CONCLUSIONS: MBCT-IBS has the potential to reduce IBS symptoms and increase quality of life. MBCT-IBS may exert its effect on IBS symptoms via reducing maladaptive illness cognitions and activating changes in self-processing (reducing biases in self-referent processing of illness and health and increasing nonjudgmental awareness). (PsycINFO Database Record (c) 2020 APA, all rights reserved).